Pharmacological and Non-Pharmacological Interventions in Diabetes Mellitus: Effects on Epicardial Adipose Tissue
International Journal of Molecular Sciences · 23.09.2025 · 26 (19) · 9271
DOI: 10.3390/ijms26199271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.09.2025. Verfasst von Krzysztof Kuleta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b…. Hauptthemen laut MEDLINE: Pericardium, Adipose Tissue, Diabetes Mellitus, Hypoglycemic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) has emerged as a significant issue for both individual patients and global health. Elevated blood glucose levels lead to complications affecting the cardiovascular system. Due to this fact and the growing population of patients with DM, it is crucial to broaden the knowledge concerning DM pathogenesis, allowing for the prevention and alleviation of organ-specific complications. Nowadays, pharmacological and non-pharmacological approaches are implicated in DM management. Epicardial adipose tissue (EAT) was indicated to modulate the impact of diabetes mellitus on the heart. Emerging evidence indicates that antidiabetic drugs can significantly influence EAT, often independently of their glucose-lowering effects, suggesting additional cardiometabolic benefits. However, not all drug classes, and even agents within the same class, exhibit identical effects on EAT, highlighting that some therapies may be preferred over others for cardiovascular benefit. Lifestyle interventions, commonly recommended to patients with DM, might also target epicardial fat. This article extensively reviews the impact of current DM treatment on EAT and depicts potential mechanisms. It also aims to identify gaps in knowledge and potential future directions. Insights from this work may guide future research and therapeutic strategies aimed at reducing cardiovascular risk in patients with DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.
- Doctoral School, Medical University of Warsaw, 02-097 Warsaw, Poland.
- Department of Invasive Cardiology, Independent Public Specialist Western Hospital John Paul II, Lazarski University, Daleka 11, 05-825 Grodzisk Mazowiecki, Poland.
ORCID-Profile: Krzysztof Kuleta, Kamil Krauz, Karol Momot, Maciej Zarębiński, Małgorzata Wojciechowska
Zitieren
APA
Kuleta, K., Krauz, K., Żmuda, J., Momot, K., Zarębiński, M., Poprawa, I., & Wojciechowska, M. (2025). Pharmacological and Non-Pharmacological Interventions in Diabetes Mellitus: Effects on Epicardial Adipose Tissue. International Journal of Molecular Sciences, 26(19), 9271. https://doi.org/10.3390/ijms26199271
Vancouver
Kuleta K, Krauz K, Żmuda J, Momot K, Zarębiński M, Poprawa I, et al. Pharmacological and Non-Pharmacological Interventions in Diabetes Mellitus: Effects on Epicardial Adipose Tissue. International Journal of Molecular Sciences. 2025;26(19):9271. doi:10.3390/ijms26199271
BibTeX
@article{Kuleta2025,
author = {Kuleta, Krzysztof and Krauz, Kamil and Żmuda, Jakub and Momot, Karol and Zarębiński, Maciej and Poprawa, Izabela and Wojciechowska, Małgorzata},
title = {Pharmacological and Non-Pharmacological Interventions in Diabetes Mellitus: Effects on Epicardial Adipose Tissue},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9271},
doi = {10.3390/ijms26199271}
}
EUVIMED